Development Level

Tbio 3 | 11,651
Tclin 1 | 612

IMPC Phenotype

decreased body weight 1 | 161
decreased circulating HDL chol... 1 | 68
decreased circulating LDL chol... 1 | 38
decreased circulating alanine ... 1 | 47
decreased circulating choleste... 1 | 93
decreased circulating serum al... 1 | 82
decreased circulating total pr... 1 | 49
decreased lactate dehydrogenas... 1 | 16
preweaning lethality, complete... 1 | 979

Disease

Carcinoma 3 | 11,493
medulloblastoma, large-cell 3 | 6,241
ovarian cancer 3 | 8,520
pancreatic cancer 3 | 2,398
primary pancreatic ductal adenocarcinoma 3 | 1,109
Breast cancer 2 | 3,578
Cancer 2 | 2,499
Down syndrome 2 | 499
Immune system cancer 2 | 140
Kidney cancer 2 | 2,613
Lymphoid leukemia 2 | 160
astrocytoma 2 | 1,146
atypical teratoid / rhabdoid tumor 2 | 5,112
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 4,679
group 3 medulloblastoma 2 | 4,104
non-small cell lung cancer 2 | 2,890
osteosarcoma 2 | 7,950
psoriasis 2 | 6,694
Abnormality of basophils 1 | 3
Adenocarcinoma 1 | 122
Astrocytoma, Pilocytic 1 | 3,081
Blastic phase chronic myeloid leukemia 1 | 58
Bone Diseases, Developmental 1 | 27
Breast Neoplasms 1 | 445
Carcinogenesis 1 | 8
Chronic Myelocytic Leukemia Accelerated Phase 1 | 59
Chronic eosinophilic leukemia 1 | 11
Chronic myeloid leukemia 1 | 12
Chronic phase chronic myeloid leukemia 1 | 45
Decrease in appetite 1 | 8
Decreased platelet count 1 | 111
Dermatofibrosarcoma protuberans 1 | 15
Doyne honeycomb retinal dystrophy 1 | 9
Duchenne muscular dystrophy 1 | 601
Endometriosis 1 | 540
Esophageal Neoplasms 1 | 69
Failure to Thrive 1 | 1
Fatigue 1 | 182
Fever 1 | 138
Fractures, Bone 1 | 13
Gastrointestinal stromal tumor 1 | 62
Globe disease 1 | 67
Heart Defects, Congenital 1 | 37
Hypereosinophilic syndrome 1 | 71
Idiopathic hypereosinophilic syndrome 1 | 10
Increased number of platelets 1 | 14
Juvenile rheumatoid arthritis 1 | 111
Leukemia, Chronic Myeloid 1 | 2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 | 20
Leukocytosis 1 | 17
Liver cancer 1 | 604
Liver neoplasms 1 | 130
Mammary Neoplasms 1 | 425
Multiple myeloma 1 | 1,332
Musculoskeletal Abnormalities 1 | 6
Myelodysplastic/ Myeloproliferative Diseases associated with Platelet-derived Growth Factor Receptor 1 | 9
Myeloid Leukemia, Chronic 1 | 23
Myeloproliferative disease 1 | 16
Neoplasms, Experimental 1 | 40
Osteoporosis 1 | 363
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 1 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 1 | 47
Polycystic ovary syndrome 1 | 360
Polycythemia vera 1 | 27
Precancerous Conditions 1 | 80
Precursor Cell Lymphoblastic Leukemia Lymphoma 1 | 43
Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 | 49
Splenomegaly 1 | 190
Systemic mast cell disease 1 | 12
Thrombocytopenia 1 | 197
Thrombocytosis 1 | 38
Waldenstrons macroglobulinemia 1 | 765
Weight Gain 1 | 100
acute T cell leukemia 1 | 17
acute lymphocytic leukemia 1 | 33
acute myeloid leukemia 1 | 783
adrenocortical carcinoma 1 | 1,428
adult high grade glioma 1 | 3,801
astrocytic glioma 1 | 2,597
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 510
breast carcinoma 1 | 1,638
cutaneous lupus erythematosus 1 | 1,057
diabetes mellitus 1 | 1,728
esophageal adenocarcinoma 1 | 737
glioblastoma 1 | 5,792
hepatocellular carcinoma 1 | 547
interstitial cystitis 1 | 2,312
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,291
invasive ductal carcinoma 1 | 2,951
juvenile dermatomyositis 1 | 1,187
lung adenocarcinoma 1 | 2,716
lung cancer 1 | 4,740
oligodendroglioma 1 | 2,850
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 2,010
tuberculosis and treatment for 6 months 1 | 409

Tissue

Blood and immune system 4 | 16,909
Cardiovascular System 4 | 15,192
Digestive Tract 4 | 17,369
Endocrine System 4 | 18,159
Female tissues 4 | 17,400
Male tissues 4 | 17,142
Respiratory system 4 | 16,393
Skin and soft tissues 4 | 17,230
Liver and Pancreas 3 | 16,750
Nervous System 3 | 16,725
Urinary Tract 3 | 16,678

Target Family

Non-IDG 3 | 12,091
Kinase 1 | 634

GO Process

positive regulation of interle... 4 | 4
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Tyrosine-protein kinase ABL1 ABL1 Tclin Kinase -3.51854 3418.5 1661
V-set domain-containing T-cell activation inhibitor 1 VTCN1 Tbio Non-IDG -2.20033 178.5 556
Beta-defensin 124 DEFB124 Tbio Non-IDG 0.27 0.76 17
Spectrin beta chain, non-erythrocytic 1 SPTBN1 Tbio Non-IDG -1.69564 46.5 98